Resultados da pesquisa - Belal Haschimi
- A mostrar 1 - 2 resultados de 2
-
1
ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market Por Arianna Giorgetti, Annette Zschiesche, Olwen Groth, Belal Haschimi, Martin Scheu, Guido Pelletti, Paolo Fais, Frank Mußhoff, Volker Auwärter
Publicado em 2024Artigo -
2
A transnational perspective on the evolution of the synthetic cannabinoid receptor agonists market: Comparing prison and general populations Por Caitlyn Norman, Sebastian Halter, Belal Haschimi, Dean Acreman, Josie Smith, Alex J. Krotulski, Amanda L A Mohr, Barry K. Logan, Niamh NicDaéid, Volker Auwärter, Craig McKenzie
Publicado em 2021Artigo